Loading insider details...
Latest Form 4 (Jun 23, 2026): Grant/Award of 95,400 ALLO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 95,400 | n/a |
| Jun 24, 2025 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 95,400 | n/a |
| Dec 9, 2024 | Allogene Therapeutics, Inc. (ALLO) | Sale | 9,221 | $19.9K |
| Jun 7, 2024 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 61,475 | n/a |
| Jun 3, 2024 | Allogene Therapeutics, Inc. (ALLO) | Sale | 11,200 | $26.2K |
| Jun 15, 2023 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 74,561 | n/a |
| Jun 17, 2022 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 44,178 | n/a |
| Jun 11, 2021 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 16,498 | n/a |
| Jun 9, 2020 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 9,969 | n/a |